Friday, September 27, 2019

Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating to EpiPen

The Securities and Exchange Commission today announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and disclosure failures relating to a Department of Justice (DOJ) probe into whether Mylan overcharged Medicaid by…
Read the Full Press Release
Want to talk to a securities lawyer? Call Sallah Astarita & Cox at 212-509-6544.